These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 37372359)
1. Classification of Acute Myeloid Leukemia by Cell-Free DNA 5-Hydroxymethylcytosine. Shao J; Shah S; Ganguly S; Zu Y; He C; Li Z Genes (Basel); 2023 May; 14(6):. PubMed ID: 37372359 [TBL] [Abstract][Full Text] [Related]
2. Cell-free DNA 5-hydroxymethylcytosine is an emerging marker of acute myeloid leukemia. Shao J; Wang S; West-Szymanski D; Karpus J; Shah S; Ganguly S; Smith J; Zu Y; He C; Li Z Sci Rep; 2022 Jul; 12(1):12410. PubMed ID: 35859008 [TBL] [Abstract][Full Text] [Related]
3. 5-Hydroxymethylcytosine correlates with epigenetic regulatory mutations, but may not have prognostic value in predicting survival in normal karyotype acute myeloid leukemia. Ahn JS; Kim HJ; Kim YK; Lee SS; Ahn SY; Jung SH; Yang DH; Lee JJ; Park HJ; Choi SH; Jung CW; Jang JH; Kim HJ; Moon JH; Sohn SK; Won JH; Kim SH; Michael S; Minden MD; Kim DD Oncotarget; 2017 Jan; 8(5):8305-8314. PubMed ID: 28039446 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical loss of 5-hydroxymethylcytosine expression in acute myeloid leukaemia: relationship to somatic gene mutations affecting epigenetic pathways. Magotra M; Sakhdari A; Lee PJ; Tomaszewicz K; Dresser K; Hutchinson LM; Woda BA; Chen BJ Histopathology; 2016 Dec; 69(6):1055-1065. PubMed ID: 27458708 [TBL] [Abstract][Full Text] [Related]
5. DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemia. Rampal R; Alkalin A; Madzo J; Vasanthakumar A; Pronier E; Patel J; Li Y; Ahn J; Abdel-Wahab O; Shih A; Lu C; Ward PS; Tsai JJ; Hricik T; Tosello V; Tallman JE; Zhao X; Daniels D; Dai Q; Ciminio L; Aifantis I; He C; Fuks F; Tallman MS; Ferrando A; Nimer S; Paietta E; Thompson CB; Licht JD; Mason CE; Godley LA; Melnick A; Figueroa ME; Levine RL Cell Rep; 2014 Dec; 9(5):1841-1855. PubMed ID: 25482556 [TBL] [Abstract][Full Text] [Related]
6. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Ko M; Huang Y; Jankowska AM; Pape UJ; Tahiliani M; Bandukwala HS; An J; Lamperti ED; Koh KP; Ganetzky R; Liu XS; Aravind L; Agarwal S; Maciejewski JP; Rao A Nature; 2010 Dec; 468(7325):839-43. PubMed ID: 21057493 [TBL] [Abstract][Full Text] [Related]
7. Characterization of acute myeloid leukemia based on levels of global hydroxymethylation. Kroeze LI; Aslanyan MG; van Rooij A; Koorenhof-Scheele TN; Massop M; Carell T; Boezeman JB; Marie JP; Halkes CJ; de Witte T; Huls G; Suciu S; Wevers RA; van der Reijden BA; Jansen JH; Blood; 2014 Aug; 124(7):1110-8. PubMed ID: 24986689 [TBL] [Abstract][Full Text] [Related]
8. Genome-wide characterization of dynamic DNA 5-hydroxymethylcytosine and TET2-related DNA demethylation during breast tumorigenesis. Wu SL; Yang L; Huang C; Li Q; Ma C; Yuan F; Zhou Y; Wang X; Tong WM; Niu Y; Jin F Clin Epigenetics; 2024 Sep; 16(1):125. PubMed ID: 39261937 [TBL] [Abstract][Full Text] [Related]
9. Cell-free DNA 5-hydroxymethylcytosine is highly sensitive for MRD assessment in acute myeloid leukemia. Shao J; Shah S; Ganguly S; Zu Y; He C; Li Z Clin Epigenetics; 2023 Aug; 15(1):134. PubMed ID: 37620919 [TBL] [Abstract][Full Text] [Related]
10. Distinct and overlapping control of 5-methylcytosine and 5-hydroxymethylcytosine by the TET proteins in human cancer cells. Putiri EL; Tiedemann RL; Thompson JJ; Liu C; Ho T; Choi JH; Robertson KD Genome Biol; 2014 Jun; 15(6):R81. PubMed ID: 24958354 [TBL] [Abstract][Full Text] [Related]
11. Cytosine 5-hydroxymethylation regulated kit gene expression in acute myeloid leukemia. Xue YM; Cheng HC; Wang JH; Wang W; Miao L J Biol Regul Homeost Agents; 2019; 33(2):345-353. PubMed ID: 30972998 [TBL] [Abstract][Full Text] [Related]
12. Human blood cell levels of 5-hydroxymethylcytosine (5hmC) decline with age, partly related to acquired mutations in TET2. Buscarlet M; Tessier A; Provost S; Mollica L; Busque L Exp Hematol; 2016 Nov; 44(11):1072-1084. PubMed ID: 27475703 [TBL] [Abstract][Full Text] [Related]
13. 5-Hydroxymethylcytosine signature in circulating cell-free DNA as a potential diagnostic factor for early-stage colorectal cancer and precancerous adenoma. Xiao Z; Wu W; Wu C; Li M; Sun F; Zheng L; Liu G; Li X; Yun Z; Tang J; Yu Y; Luo S; Sun W; Feng X; Cheng Q; Tao X; Wu S; Tao J Mol Oncol; 2021 Jan; 15(1):138-150. PubMed ID: 33107199 [TBL] [Abstract][Full Text] [Related]
14. MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL. Poole CJ; Lodh A; Choi JH; van Riggelen J Epigenetics Chromatin; 2019 Jul; 12(1):41. PubMed ID: 31266538 [TBL] [Abstract][Full Text] [Related]
15. Mutations in TET2 and DNMT3A genes are associated with changes in global and gene-specific methylation in acute myeloid leukemia. Ponciano-Gómez A; Martínez-Tovar A; Vela-Ojeda J; Olarte-Carrillo I; Centeno-Cruz F; Garrido E Tumour Biol; 2017 Oct; 39(10):1010428317732181. PubMed ID: 28992762 [TBL] [Abstract][Full Text] [Related]
16. A Highly Sensitive and Robust Method for Genome-wide 5hmC Profiling of Rare Cell Populations. Han D; Lu X; Shih AH; Nie J; You Q; Xu MM; Melnick AM; Levine RL; He C Mol Cell; 2016 Aug; 63(4):711-719. PubMed ID: 27477909 [TBL] [Abstract][Full Text] [Related]
17. 5-Hydroxymethylcytosine-mediated active demethylation is required for mammalian neuronal differentiation and function. Stoyanova E; Riad M; Rao A; Heintz N Elife; 2021 Dec; 10():. PubMed ID: 34919053 [TBL] [Abstract][Full Text] [Related]
18. TET2-Mediated Spatiotemporal Changes of 5-Hydroxymethylcytosine During Organogenesis in the Late Mouse Fetus. Li X; Xie F; Jin J; Wu Y; Luo Z; Zhang F; Zhang S; Chen D; Liu A Anat Rec (Hoboken); 2019 Jun; 302(6):954-963. PubMed ID: 30369084 [TBL] [Abstract][Full Text] [Related]
19. Homoharringtonine exhibits potent anti-tumor effect and modulates DNA epigenome in acute myeloid leukemia by targeting SP1/TET1/5hmC. Li C; Dong L; Su R; Bi Y; Qing Y; Deng X; Zhou Y; Hu C; Yu M; Huang H; Jiang X; Li X; He X; Zou D; Shen C; Han L; Sun M; Skibbe J; Ferchen K; Qin X; Weng H; Huang H; Song C; Chen J; Jin J Haematologica; 2020 Jan; 105(1):148-160. PubMed ID: 30975912 [TBL] [Abstract][Full Text] [Related]
20. Changes in DNA 5-Hydroxymethylcytosine Levels and the Underlying Mechanism in Non-functioning Pituitary Adenomas. Xu Y; Niu Y; Deng K; Pan H; Feng F; Gong F; Tong WM; Chen S; Lu L; Wang R; You H; Yao Y; Zhu H Front Endocrinol (Lausanne); 2020; 11():361. PubMed ID: 32774324 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]